800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NAIL-IT)

view all Clinical Trials

Overview

Evaluation of safety and thrombolytic effect of ascending doses of TS23 in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (PE).

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.